Damiano de Felice presents AMR Benchmark at CPhL Worldwide side-event
Damiano de Felice will join a CPhL Worldwide side-event held in Frankfurt on October 23, 2017, to discuss the rise of antimicrobial resistance (AMR) and the role of the pharmaceutical industry in addressing AMR. Damiano will present the Foundation’s forthcoming Antimicrobial Resistance Benchmark, which is the first independently developed framework for evaluating how pharmaceutical companies respond to AMR.
Date
23 October 2017
The Antimicrobial Resistance Benchmark will map the actions of 30 companies against agreed priorities for limiting AMR, structured around three research areas. It also aims to incentivise and guide pharmaceutical company action on AMR.